Cartesian Therapeutics, Inc. (RNAC)
NASDAQ·Healthcare·Biotechnology
$6.89
-2.82%
Mkt Cap $234.55M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$42.67
Range $40.00 – $45.00
Implied Upside
+519.3%
Consensus $42.67 vs current $6.89
NASDAQ·Healthcare·Biotechnology
$6.89
-2.82%
Mkt Cap $234.55M
No recent rating data.
Price Target (3 analysts)
$42.67
Range $40.00 – $45.00
+519.3%
Consensus $42.67 vs current $6.89